Computational methods for scaffold hopping

Wiley Interdisciplinary Reviews: Computational Molecular Science

Volumn 2, Issue 6, 2012, Pages 842-867

  Schuffenhauer, Ansgar ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867394682     PISSN: 17590876     EISSN: 17590884     Source Type: Journal    
DOI: 101002/wcms1106     Document Type: Article

References (126)

1. Brown N, Jacoby E On scaffolds and hopping in medicinal chemistry Mini Rev Med Chem 2006, 6:1217-1229
2. Mauser H, Guba W Recent developments in de novo design and scaffold hopping Curr Opin Drug Discov Dev 2008, 11:365-374
3. Istvan ES, Deisenhifer J Structural mechanism for statin inhibition of HMG-CoA reductase Science 2001, 292:1160-1164
4. Roth DB Trans-6-2-(3- or 4-carboxamido-sub-stituted pyrrol-1-yl)alkyl -4-hydroxypyran-2-one inhibitors of cholesterol synthesis Patent US4681893
5. Cohen NC Structure-based drug design and the discovery of Aliskiren (Tekturna®): perseverance and creativity to overcome an R&D pipeline challenge Chem Biol Drug Des 2007, 70:557-565
6. Olah M, Rad R, Ostopovici L, Bora A, Hadaruga N, Hadaruga D, Moldovan R, Fulias A, Mracec M, Oprea TI WOMBAT and WOMBAT-PK: bioactivity databases for lead and drug discovery In: Schreiber SL, Kapoor TM, Wess G, eds Chemical Biology: From Small Molecules to Systems Biology and Drug Design New York: Wiley-VCH; 2007, 760-786
7. WOMBAT database Available at: http://wwwsunsetmolecularcom/indexphp?option=com_content&view=article&id=15&Itemid=10 (Accessed January 9, 2012)
8. GOSTAR database Available at: https://gostardbcom/gostar/ (Accessed January 11, 2012)
9. ChemBL database Available at: https://wwwebiacuk/chembl/ (Accessed January 11, 2012)
10. Nettles JH, Jenkins JL, Bender A, Deng Z, Davies JW, Glick M Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors J Med Chem 2006, 49:6802-6810
11. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK Relating protein pharmacology by ligand chemistry Nat Biotechnol 2007, 25:197-206
12. Gregori-Pugjané G, Mestres J A ligand-based approach to mining the chemogenomic space of drugs Comb Chem High Throughput Screen 2008, 11:669-676
13. Koustoukas A, Simms B, Kirchmair J, Bond PJ, Whitmore AV, Zimmer S, Young MP, Jenkins JL, Glick M, Glen RC From in silico target prediction to multi-target drug design: current databases, methods and applications J Proteomics 2011, 74:2554-2574
14. Bickle M The beautiful cell: high-content screening in drug discovery Anal Bioanal Chem 2010, 398:219-226
15. Butcher RA, Bhullar BS, Perlstein EO, Marsischky G, LaBaer J, Schreiber SL Microarray-based method for monitoring yeast overexpression strains reveals small-molecule target in TOR pathway Nat Chem Biol 2006, 2:103-109
16. Raida M Drug target deconvolution by chemical proteomics Curr Opin Chem Biol 2011, 15:570-575
17. Yuriev E, Agostino M, Ramsland PA Challenges and advances in computational docking: 2009 in review J Mol Recognit 2011, 24:149-164
18. Hartenfeller M, Schneider G De novo drug design In: Bajorath J, ed Chemoinformatics and Computational Chemical Biology, Methods in Molecular Biology Heidelberg: Springer Science+Business Media; 2011, 299-323
19. Horvath D Pharmacophore-based virtual screening In: Bajorath J, ed Chemoinformatics and Computational Chemical Biology, Methods in Molecular Biology Heidelberg: Springer Science+Business Media; 2011, 261-298
20. Wolber G, Seidel T, Bendix F, Langer T Molecule-pharmacophore superpositioning and pattern matching in computational drug-design Drug Disc Today 2008, 13:23-29
21. Wolber G, Langer T LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J Chem Inf Model 2005, 45:160-169
22. LigandScout Available at: http://wwwinteligandcom/ligandscout/ (Accessed January 9, 2012)
23. Olla S, Manetti F, Crespan E, Maga G, Angelucci A, Schenone S, Bologna M, Botta M Indolyl-pyrrolone as new scaffold for Pim1 inhibitors Bioorg Med Chem Lett 2009, 19:1512-1516
24. Martin YC, Bures MG, Danaher EA, DeLazzer J, Lico I, Pavlik PA A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists J Comput Aided Mol Des 1993, 7:83-102
25. Shepphird JK, Clark RD A marriage made in torsional space: using GALAHAD models to drive pharmacophore multiplet searches J Comput Aided Mol Des 2006, 20:763-71
26. Dixon SL, Smondyrev AL, Knoll EH, Rao SN, Shaw DE, Friesner RA PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1 Methodology and preliminary results J Comput Aided Mol Des 2006, 20:647-671
27. Wu J-S, Peng Y-H, Wu J-M, Hsieh CJ, Wu SH, Coumar MS, Song JS, Lee JC, Tsai CH, Chen CT, et al Discovery of non-glycoside sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening J Med Chem 2010, 53:8770-8774
28. Molecular Operating Environment (MOE) Available at: http://wwwchemcompcom/software-ph4htm (Accessed January 9, 2012)
29. Phase by Schrödinger Available at: https://wwwschrodingercom/products/14/13/ (Accessed January 9, 2012)
30. Catalyst and pipeline pilot by Accelrys Available at: http://accelryscom/products/datasheets/pharmacophore-modelingpdf (Accessed January 9, 2012)
31. Foloppe N, Chen I-J Conformational sampling and energetics of drug-like molecules Curr Med Chem 2009, 16:3381-3413
32. Knox AJS, Meegan MJ, Carta G, Lloyd DG Considerations in compound database preparations-"hidden" impact on virtual screening results J Chem Inf Model 2005, 45:1908-1919
33. Hurst T Flexible 3D searching: the directed tweak technique J Chem Inf Comput Sci 1994, 34:190-196
34. Unity and dbtop by Tripos Available at: http://wwwtriposcom/indexphp?family=modules, SimplePage, &page=UNITY (Accessed January 9, 2012)
35. Grant JA, Gallardo MA, Pickup BT A fast method of molecular shape comparison: a simple application of a Gaussian description of molecular shape J Comp Chem 1998, 17:1653-1666
36. ROCS, EON and OMEGA by OpenEye Available at: http://wwweyesopencom/ (Accessed January 9, 2012)
37. Rush TS, Grant JA, Mosyak L, Nicholls A A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction J Med Chem 2005, 48:1489-1495
38. Hawkins PCD, Skillmann AG, Warren GL, Ellingson BA, Stahl MT Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database J Chem Inf Model 2010, 50:572-584
39. Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A, Rosen D, Thomas JM, Izumi M, Ganesan A, et al Identification of a chemical probe for NAADP by virtual screening Nat Chem Biol 2009, 5:220-226
40. Liu X, Jiang H, Li H SHAFTS: a hybrid approach for 3D molecular similarity calculation 1 Method and assessment of virtual screening J Chem Inf Model 2011, 51:2372-2385
41. Lu W, Liu X, Cao X, Xue M, Liu K, Zhao Z, Shen X, Jiang H, Xu Y, Huang J, et al SHAFTS: a hybrid approach for 3D molecular similarity calculation 2 Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration J Med Chem 2011, 54:3564-3574
42. Wild DJ, Willett P Similarity searching in files of three-dimensional chemical structures Alignment of molecular electrostatic potential fields with a genetic algorithm J Chem Inf Comput Sci 1996, 36:159-167
43. Thorner DA, Wild DJ, Willett P, Wright PM Similarity searching in files of three-dimensional chemical structures: flexible field-based searching of molecular electrostatic potentials J Chem Inf Comput Sci 1996, 36:900-908
44. Cheeseright TJ, Mackey MD, Melville JL, Vinter JG FieldScreen: virtual screening using molecular fields Application to the DUD data set J Chem Inf Model 2008, 48:2108-2117
45. Cresset Available at: http://wwwcresset-groupcom/ (Accessed on January 10, 2012)
46. Vinter JG Extended electron distributions applied to the molecular mechanics of intermolecular interactions II Organic complexes J Comput Aided Mol Des 1996, 10:417-426
47. Bellenie BR, Barton NP, Emmons AJ, Heer JP, Salvago C Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design Bioorg Med Chem Lett 2009, 19:990-994
48. Cheeseright TJ, Holm M, Lehmann F, Luik S, Gottert M, Melville JL, Laufer S Novel lead structures for p38 MAP kinase via FieldScreen virtual screening J Med Chem 2009, 52:4200-4209
49. Goodford PJ A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J Med Chem 1985, 28:849-857
50. Carosati E, Scabiola S, Cruciani G Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field J Med Chem 2004, 47:5114-5125
51. Baroni M, Cruciani G, Sciabola S, Perruccio F, Mason JS A common reference framework for analyzing/comparing proteins and ligands Fingerprints for ligands and proteins (FLAP): theory and application J Chem Inf Model 2007, 47:279-294
52. Cross S, Baroni M, Carosati E, Benedetti P, Clementi S FLAP: GRID molecular interaction fields in virtual screening Validation using the DUD data set J Chem Inf Model 2010, 50:1442-1450
53. Jenkins JL, Glick M, Davies JW A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes J Med Chem 2004, 47:6144-6159
54. von Korff M, Freyss J, Sander T Comparison of ligand- and structure-based virtual screening on the DUD data set J Chem Inf Model 2009, 49:209-231
55. Willett P Similarity searching using 2D structural fingerprints In: Bajorath J, ed Chemoinformatics and Computational Chemical Biology, Methods in Molecular Biology Heidelberg: Springer Science+Business Media; 2011, 133-158
56. Digital Chemistry Available at: http://wwwdigitalchemistrycouk (Accessed December 20, 2011)
57. Daylight Available at: wwwdaylightcom (Accessed December 20, 2011)
58. Rogers D, Hahn M Extended-connectivity fingerprints J Chem Inf Model 2010, 50:742-754
59. Holliday JD, Salim N, Whittle M, Willett P Analysis and display of the size dependence of chemical similarity coefficients J Chem Inf Comput Sci 2003, 43:819-828
60. Melville JL, Burke EK, Hirst JD Machine learning in virtual screening Comb Chem High Throughput Screen 2009, 12:332-343
61. Hastie T, Tibshirani R, Friedmann F The Elements of Statistical Learning New-York: Springer Science+Business Media; 2001
62. Ballester PJ, Richards G Ultrafast shape recognition to search compound databases for similar molecular shapes J Comput Chem 2007, 28:1711-1723
63. Russel AJ, Sim E, Davies SG, Westwook IM, Kawamura A, Crawford MHJ, Laurieri N 1, 4-quinones and their sulfur analogues as useful as ligands of N-actelytransferases Patent WO 2011/055142
64. Ballester PJ, Westwood I, Laurieri N, Sim E, Richards WG Prospective virtual screening with ultrafast shape recognition: the identification of novel inhibitors of arylamine J R Soc Interface 2010, 7:335-342
65. Armstrong MS, Finn PW Improving the accuracy of ultrafast ligand-based screening: incorporating lipophilicity into ElectroShape as an extra dimension J Comput Aided Mol Des 2011, 25:785-790
66. Wang Q, Birod K, Angioni C, Grösch S, Geppert T, Schneider P, Rupp M, Schneider G Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors PLoS One 2011, 6:e21554
67. Bauknecht H, Zell A, Bayer H, Levi P, Wagener M, Sadowski J, Gasteiger J Locating biologically active compounds in medium-sized heterogeneous datasets by topological autocorrelation vectors: dopamine and benzodiazepine agonists J Chem Inf Comput Sci 1996, 36:1205-1213
68. Hofmann B, Franke F, Proschak E, Tanrikulu Y, Schneider P, Steinhilber D, Schneider G Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase ChemMedChem 2008, 3:1535-1538
69. Pastor M, Cruciani G, McLay I, Pickett S, Clementi S Grid-independent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors J Med Chem 2000, 43:3233-3243
70. ATP channels J Med Chem 2007, 50:2117-2126
71. McGregor MJ, Muskal SM Pharmacophore fingerprinting 1 Application to QSAR and focused library design J Chem Inf Comput Sci 1999, 39:569-574
72. Schuffenhauer A, Floersheim P, Acklin P, Jacoby E Similarity metrics for ligands reflecting the similarity of the target proteins J Chem Inf Comput Sci 2003, 43:391-405
73. Schneider G, Neidhardt W, Giller T, Schmid G "Scaffold-hopping" by topological pharmacophore search: a contribution to virtual screening Angew Chem Int Ed 1999, 38:2894-2896
74. Nærum L, N′ørskov-Lauritsen L, Olesen PH Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors Bioorg Med Chem Lett 2002, 12:1525-1528
75. Noeske T, Trifanova D, Kauss V, Renner S, Parsons CG, Schneider G, Weil T Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1 Bioorg Med Chem 2009, 17:5708-5715
76. Rogers-Evans M, Alanine AI, Bleicher KH, Kube D, Schneider G Identification of novel cannabinoid receptor ligands via evolutionary de novo design and rapid parallel synthesis QSAR Comb Sci 2004, 23:426-430
77. Alig L, Alsenz J, Andjelkovic M, Bendels S, Benardeau A, Bleicher K, Bourson A, David-Pierson P, Guba W, Hildbrand S, et al Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity J Med Chem 2008, 51:2115-2127
78. Schüller A, Suhartono M, Fechner U, Tanrikulu Y, Breitung S, Scheffer U, Göbel MW, Schneider G The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA J Comput Aided Mol Des 2008, 22:59-68
79. Gregori-Pugjané G, Mestres J SHED: shannon entropy descriptors from topological feature distributions J Chem Inf Model 2006, 46:1615-1622
80. Areias FM, Brea J, Gregori-Pugjané E, Zaki MEA, Carvalho MA, Domínguez E, Gutiérrez-de-Terán H, Proença MF, Loza MI, Mestres J In silico directed chemical probing of the adenosine receptor family Bioorg Med Chem 2010, 18:3043-3052
81. Langdon SR, Ertl P, Brown N Bioisosteric replacement and scaffold hopping in lead generation and optimization Mol Inf 2010, 29:366-385
82. Ertl P In silico identification of bioisosteric functional groups Curr Opin Drug Disc Dev 2007, 10:281-288
83. Birchall K, Gillet VJ Reduced graphs and their applications in chemoinformatics In: Bajorath J, ed Chemoinformatics and Computational Chemical Biology, Methods in Molecular Biology Heidelberg: Springer Science+Business Media; 2011, 197-212
84. Rarey M, Dixon JS Feature trees: a new molecular similarity measure based on tree matching J Comput Aided Mol Des 1998, 12:471-490
85. FTrees and Recore by BiosolveIT Available at: http://wwwbiosolveitde/ (Accessed January 12, 2012)
86. Jilek RJ, Cramer RD Topomers: a validated protocol for their self-consistent generation J Chem Inf Comput Sci 2004, 44:1221-1227
87. Cramer RD, Jilek RJ, Andrews KM dbtop: topomer similarity searching of conventional databases J Mol Graph Model 2002, 20:447-462
88. Kiss R, Sándor M, Gere A, Schmidt É, Balogh GT, Kiss B, Molnár L, Lemmen C, Keserü GM Discovery of novel histamine H4 and serotonin transporter ligands using the topological feature tree descriptor J Chem Inf Model 2012, 52:233-242
89. Cramer RD, Jilek RJ, Guessregen S, Clark SJ, Wendt B, Clark RD "Lead hopping" Validation of topomer similarity as a superior predictor of similar biological activities J Med Chem 2004, 47:6777-6791
90. Lessel U, Wellenzohn B, Lilienthal M, Claussen C Searching fragment spaces with feature trees J Chem Inf Model 2009, 49:270-279
91. 20 synthetically accessible structures J Comput Aided Mol Des 2007, 21:341-350
92. Birchall K, Gillet VJ, Harper G, Pickett SD Evolving interpretable structure-activity relationships 1 Reduced graph queries J Chem Inf Model 2008, 48:1543-1557
93. Birchall K, Gillet VJ, Harper G, Pickett SD Evolving interpretable structure-activity relationships 2 Using multiobjective optimization to derive multiple models J Chem Inf Model 2008, 48:1557-1570
94. Laurie G, Bartlett PA CAVEAT: a program to facilitate the design of organic molecules J Comput Aided Mol Des 1994, 8:51-66
95. Cohen F, Alicke B, Elliott LO, Flygare JA, Goncharov T, Keteltas SF, Franklin MC, Frankovitz S, Stephan JP, Tsui V, et al Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffold J Med Chem 2009, 52:1723-1730
96. Maass P, Schulz-Gasch T, Stahl M, Rarey M Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations J Chem Inf Model 2007, 47:390-399
97. Bergmann R, Linusson A, Zamora I, SHOP: scaffold HOPping by GRID-based similarity searches J Med Chem 2007, 50:2708-2717
98. Jakobi A-J, Mauser H, Clark T ParaFrag-an approach for surface-based similarity comparison of molecular fragments J Mol Model 2008, 14:547-558
99. Lewell XQ, Judd DB, Watson SP, Hann MM RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry J Chem Inf Comput Sci 1998, 38:511-522
100. Degen J, Wegscheid-Gerlach C, Zaliani A, Rarey M On the art of compiling and using 'drug-like' chemical fragment spaces ChemMedChem 2008, 3:1503-1507
101. Schuffenhauer A, Zimmermann J, Stoop R, van der Vyver J-J, Lecchini S, Jacoby E An ontology for pharmaceutical ligands and its application for in silico screening and library design J Chem Inf Comput Sci 2002, 42:947-955
102. Weill N, Rognan D Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands J Chem Inf Model 2009, 49:1049-1062
103. Meslamani J, Rognan D Enhancing the accuracy of chemogenomic models with a three-dimensional binding site kernel J Chem Inf Model 2011, 51:1593-1603
104. Yabuuchi H, Niijima S, Takematsu H, Ida T, Hirokawa T, Hara T, Ogawa T, Minowa Y, Tsujimoto G, Okuno Y Analysis of multiple compound-protein interactions reveals novel bioactive molecules Mol Syst Biol 2011, 7:472-483
105. Okuno Y, Yang J, Taneishi K, Yabuuchi H, Tsujimoto G GLIDA:GPCR-ligand database for chemical genomic drug discovery Nucleic Acids Res 2006, 34:D673-D677
106. Todeschini R Dragon Available at: http://wwwtaletemiit/products/dragon_descriptionhtm (Accessed February 1, 2012)
107. Leslie CS, Eskin E, Cohen A, Weston J, Noble WS Mismatch string kernels for discriminative protein classification Bioinformatics 2004, 20:467-476
108. Li ZR, Lin HH, Han LY, Jiang L, Chen X, Chen YZ PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence Nucleic Acids Res 2006, 34:W32-W37
109. Wang F, Liu D, Wang H, Luo C, Zheng M, Liu H, Zhu W, Luo X, Zhang J, Jiang H Computational screening for active compounds targeting protein sequences: methodology and experimental validation J Chem Inf Model 2011, 51:2821-2818
110. Bemis GW, Murcko MA The properties of known drugs 1 Molecular frameworks J Med Chem 1996, 39:2887-2893
111. Xu J, Stevenson J Drug-like index: a new approach to measure drug-like compounds and their diversity J Chem Inf Comput Sci 2000, 40:1177-1187
112. Huang N, Shoichet BK, Irwin JJ Benchmarking sets for molecular docking J Med Chem 2006, 49:6789-6801
113. Good AC, Oprea TI Optimization of CAMD techniques 3 Virtual screening enrichment studies: a help or hindrance in tool selection? J Comput Aided Mol Des 2008, 22:169-178
114. Ripphausen P, Wassermann AM, Bajorath J REPROVIS-DB: a benchmark system for ligand-based virtual screening derived from reproducible prospective applications J Chem Inf Model 2011, 51:2467-2473
115. Schuffenhauer A, Ertl P, Roggo S, Wetzel S, Koch MA, Waldmann H The scaffold tree-visualization of the scaffold universe by hierarchical scaffold classification J Chem Inf Model 2007, 47:47-58
116. Varin T, Schuffenhauer A, Ertl P, Renner S Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data J Chem Inf Model 2011, 51:1528-1538
117. Schuffenhauer A, Varin T Rule-based classification of chemical structures by scaffold Mol Inf 2011, 30:646-664
118. Clark AM, Labute P Detection and assignment of common scaffolds in project databases of lead molecules J Med Chem 2009, 52:469-483
119. Li R, Stumpfe D, Vogt M, Geppert H, Bajorath J Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential J Chem Inf Model 2011, 51:2507-2514
120. Markush Search and Enumeration Toolkit from Chemaxon Available at: http://wwwchemaxoncom/products/markush-ip/ (Accessed December 20, 2012)
121. Zhang Q, Muegge I Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring J Med Chem 2006, 49:1536-1548
122. Tresadern G, Bemporad D, Howe T A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor J Mol Graph Mod 2009, 27:860-870
123. Gardiner EJ, Holliday JD, O'Dowd C, Willett P Effectiveness of 2D fingerprints for scaffold hopping Future Med Chem 2011, 3:405-414
124. Vogt M, Stumpfe D, Geppert H, Bajorath J Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening J Med Chem 2010, 53:5707-5715
125. Moffat K, Gillet VJ, Whittle M, Bravi G, Leach AR A comparison of field-based similarity searching methods: CatShape, FBSS, and ROCS J Chem Inf Model 2008, 48:719-729
126. B antagonists J Comput Aided Mol Des 2009, 23:869-881